guest ::
| Home > Publications database > Influence of the Maillard Reaction to Prion Protein Aggregation > print |
| Home > Publications database > Influence of the Maillard Reaction to Prion Protein Aggregation > print |
| 001 | 9743 | ||
| 005 | 20200402205832.0 | ||
| 024 | 7 | _ | |2 pmid |a pmid:20370497 |
| 024 | 7 | _ | |2 DOI |a 10.1089/rej.2009.0954 |
| 024 | 7 | _ | |2 WOS |a WOS:000277602200022 |
| 037 | _ | _ | |a PreJuSER-9743 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 084 | _ | _ | |2 WoS |a Geriatrics & Gerontology |
| 100 | 1 | _ | |a Panza, G. |b 0 |0 P:(DE-HGF)0 |
| 245 | _ | _ | |a Influence of the Maillard Reaction to Prion Protein Aggregation |
| 260 | _ | _ | |a Larchmont, NY |b Liebert |c 2010 |
| 300 | _ | _ | |a |
| 336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a article |2 DRIVER |
| 440 | _ | 0 | |a Rejuvenation Research |x 1549-1684 |0 18202 |y 2 |v 13 |
| 500 | _ | _ | |a Record converted from VDB: 12.11.2012 |
| 520 | _ | _ | |a Prion diseases are fatal neurodegenerative diseases that occur either spontaneously or genetically or are caused by infection. Spontaneously occurring prion diseases are age related. The infectious agents, called prions, are proteinaceous infectious particles, composed mainly of the host-encoded prion protein (PrP) in a misfolded, insoluble, and aggregated isoform. Advanced glycation end products (AGEs) are well known to contribute to protein misfolding, insolubility, and aggregation. Thus, we studied if AGE-modification could influence PrP aggregation. We analyzed PrP preparations immunochemically to determine if they contain AGE-modified PrP. We also studied the influence of AGE modifications on the PrP aggregation process in vitro. |
| 536 | _ | _ | |a Funktion und Dysfunktion des Nervensystems |c P33 |2 G:(DE-HGF) |0 G:(DE-Juel1)FUEK409 |x 0 |
| 536 | _ | _ | |a BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung |c P45 |0 G:(DE-Juel1)FUEK505 |x 1 |
| 588 | _ | _ | |a Dataset connected to Web of Science, Pubmed |
| 650 | _ | 2 | |2 MeSH |a Animals |
| 650 | _ | 2 | |2 MeSH |a Antibodies: pharmacology |
| 650 | _ | 2 | |2 MeSH |a CHO Cells |
| 650 | _ | 2 | |2 MeSH |a Chemical Precipitation |
| 650 | _ | 2 | |2 MeSH |a Cricetinae |
| 650 | _ | 2 | |2 MeSH |a Cricetulus |
| 650 | _ | 2 | |2 MeSH |a Glycosylation End Products, Advanced: chemistry |
| 650 | _ | 2 | |2 MeSH |a Glycosylation End Products, Advanced: immunology |
| 650 | _ | 2 | |2 MeSH |a Glycosylation End Products, Advanced: metabolism |
| 650 | _ | 2 | |2 MeSH |a Maillard Reaction |
| 650 | _ | 2 | |2 MeSH |a Prions: chemistry |
| 650 | _ | 2 | |2 MeSH |a Prions: metabolism |
| 650 | _ | 2 | |2 MeSH |a Protein Multimerization: physiology |
| 650 | _ | 2 | |2 MeSH |a Protein Processing, Post-Translational |
| 650 | _ | 2 | |2 MeSH |a Recombinant Proteins: chemistry |
| 650 | _ | 2 | |2 MeSH |a Recombinant Proteins: metabolism |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Antibodies |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Glycosylation End Products, Advanced |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Prions |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Recombinant Proteins |
| 650 | _ | 7 | |a J |2 WoSType |
| 700 | 1 | _ | |a Dumpitak, C. |b 1 |0 P:(DE-HGF)0 |
| 700 | 1 | _ | |a Birkmann, E. |b 2 |u FZJ |0 P:(DE-Juel1)VDB65870 |
| 773 | _ | _ | |a 10.1089/rej.2009.0954 |g Vol. 13 |q 13 |0 PERI:(DE-600)2155984-3 |t Rejuvenation research |v 13 |y 2010 |x 1549-1684 |
| 856 | 7 | _ | |u http://dx.doi.org/10.1089/rej.2009.0954 |
| 909 | C | O | |o oai:juser.fz-juelich.de:9743 |p VDB |
| 913 | 1 | _ | |k P33 |v Funktion und Dysfunktion des Nervensystems |l Funktion und Dysfunktion des Nervensystems |b Gesundheit |0 G:(DE-Juel1)FUEK409 |x 0 |
| 913 | 1 | _ | |k P45 |v BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung |l Biologische Informationsverarbeitung |b Schlüsseltechnologien |0 G:(DE-Juel1)FUEK505 |x 1 |
| 913 | 2 | _ | |a DE-HGF |b Key Technologies |l BioSoft Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |1 G:(DE-HGF)POF3-550 |0 G:(DE-HGF)POF3-553 |2 G:(DE-HGF)POF3-500 |v Physical Basis of Diseases |x 0 |
| 914 | 1 | _ | |y 2010 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0010 |a JCR/ISI refereed |
| 920 | 1 | _ | |k ISB-3 |l Strukturbiochemie |d 31.12.2010 |g ISB |0 I:(DE-Juel1)VDB942 |x 0 |
| 970 | _ | _ | |a VDB:(DE-Juel1)119733 |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a ConvertedRecord |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| 980 | _ | _ | |a UNRESTRICTED |
| 981 | _ | _ | |a I:(DE-Juel1)IBI-7-20200312 |
| 981 | _ | _ | |a I:(DE-Juel1)ICS-6-20110106 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|